For Whom the Bell Tolls? A Toll-Like Receptor 9 Agonist's Journey from Vaccine Adjuvant to Promising Agent in Anti-PD-1-Resistant Melanoma.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-21-1226
Abstract: SUMMARY Developing effective therapies in anti-PD-1-resistant melanoma is a key unmet need. The combination of pembrolizumab with the intralesional TLR9 agonist vidutolimod showed promise in this patient population with correlative analysis suggesting that patients with… read more here.
Keywords: tolls toll; resistant melanoma; bell tolls; anti resistant ... See more keywords
Addendum: Parker, M.; Spennemann, D. For Whom the Bell Tolls: Practitioners’ Views on Bell-Ringing Practice in Contemporary Society in New South Wales (Australia). Religions 2020, 11, 425
Sign Up to like & getrecommendations! Published in 2020 at "Religion"
DOI: 10.3390/rel11120668
Abstract: The authors would like to make the following corrections in relation to the published paper (Parker and Spennemann 2020) [...] read more here.
Keywords: bell tolls; parker spennemann; addendum parker; parker ... See more keywords